Abstract
Get full access to this article
View all access options for this article.
References
1.The Coronary Drug Project Research Group . Clofibrate and niacin in coronary heart disease . JAMA
1975 ; 231 : 360 –81 .
2.
Canner
PL
Berge
KG
Wenger
NK
, Fifteen year mortality in coronary drug project patients: Long term benefit with niacin . JAAC
1986 ; 8 : 1245 –55 .
3.
Olsson
AG
Carlson
LA
Anggard
E
, Prostacyclin production augmented in the short term by nicotinic acid . Lancet
1983 ; 2 : 565 –7 .
4.
Figge
HL
Figge
J
Souney
PF
, Nicotinic acid: A review of its clinical use in the treatment of lipid disorders . Pharmacotherapy
1988 : 8 : 287 –94 .
5.
Svedmyr
N
Harthon
L
Lundholm
L
. The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man . Clin Pharmacol Ther
1969 ; 10 : 559 –70 .
6.
Knopp
RH
Ginsberg
J
Albers
JJ
, Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin . Metabolism
1985 ; 34 : 642 –50 .
7.
Christensen
NA
Achor
RW
Berge
KG
, Nicotinic acid treatment of hypercholesteremia . JAMA
1961 ; 177 : 546 –50 .
8.
Alhadeff
L
Gualiteri
CT
Lipton
M
. Toxic effects of water-soluble vitamins . Nutr Rev
1984 ; 42 : 33 –40 .
9.
Knodel
LC
Talbert
RL
. Adverse effects of hypolipidemic drugs . Med Toxicol
1987 ; 2 : 10 –32 .
10.
Clementz
GL
Holmes
AW
. Nicotinic acid induced fulminant hepatic failure . J Clin Gastroenterol
1987 ; 9 : 582 –4 .
11.
Mullin
GE
Greenson
JK
Mitchell
MC
. Fulminant hepatic failure after ingestion of sustained-release nicotinic acid . Ann Intern Med
1989 ; 11 : 253 –5 .
12.
Baggenstoss
AH
Christensen
NA
Berge
KG
, Fine structural changes in the liver in hypercholesteremic patients receiving long-term nicotinic acid therapy . Mayo Clin Proc
1967 ; 42 : 385 –99 .
13.
Zimmerman
HJ
. Drug-induced liver disease . Drugs
1978 ; 16 : 25 –45 .
14.
Einstein
N
Baker
A
Galper
J
, Jaundice due to nicotinic acid therapy . Dig Dis
1975 ; 20 : 282 –6 .
15.
Fitzgerald
BA
Wright
JH
Atala
KD
. Bulimia nervosa. Uncovering a secret disorder . Postgrad Med
1988 ; 84 : 119 –23 .
16.
Goldbloom
DS
Kennedy
SH
Kaplan
AS
Woodside
DB
. Anorexia nervosa and bulimia nervosa . Can Med Assoc
1989 ; 140 : 1149 –54 .
17.
Orsulak
PJ
Waller
D
. Antidepressant drugs: Additional clinical uses . J Fam Pract
1989 ; 28 : 209 –16 .
18.
Hudson
JI
Pope
HG
Jr.
. Newer antidepressants in the treatment of bulimia nervosa . Psychopharmacol Bull
1987 ; 23 : 52 –7 .
19.
Humphries
LL
. Bulimia: Diagnoses and treatment . Compr Ther
1987 ; 13 : 12 –5 .
20.
Jinks
MJ
. Obesity, anorexia nervosa, bulimia, and other eating disorders . In:
Herfindal
ET
Gourly
DR
Hart
LL
, eds. Clinical pharmacy and therapeutics . 4th ed . Baltimore : Williams & Wilkins , 1988 : 669 –77 .
21.
Hinz
LD
Williamson
DA
. Bulimia and depression: A review of the affective variant hypothesis . Psychol Bull
1987 ; 102 : 150 –8 .
22.
Levy
AB
Dixon
KN
Stern
SL
. How are depression and bulimia related?
Am J Psychiatry
1988 ; 146 : 162 –9 .
23.
Hughes
PL
Wells
LA
Cunningham
CJ
Ilstrup
DM
. Treating bulimia with desipramine . Arch Gen Psych
1986 ; 43 : 182 –6 .
24.
Agras
WS
Dorian
B
Kirkley
BG
Arnow
B
Bachman
J
. Imip ramine in the treatment of bulimia: A double-blind study . Int J Eat Disord
1987 ; 6 : 29 –38 .
25.
Walsh
BT
Stewart
JW
Roose
SP
, Treatment of bulimia with phenelzine . Arch Gen Psych
1984 ; 41 : 1105 –9 .
26.
Mitchell
JE
Pyle
RL
Eckert
ED
, Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa . J Clin Psychopharmacol
1989 ; 9 : 291 –3 .
27.
Mitchell
JE
Hatsukami
D
Eckert
E
Pyle
R
. Eating disorder questionnaire . Psychopharmacol Bull
1985 ; 21 : 1025 –45 .
28.
Freeman
CPL
Hampson
M
. Fluoxetine as a treatment for bulimia nervosa . Int J Obes
1987 ; 11 (suppl 3 ): 171 –7 .